Product Information
- (9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-a-[(dibutylamino)methyl]-9H-fluorene-4-methanol
- (9Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-α-[(dibutylamino)methyl]-9H-fluorene-4-methanol
- (Z)-2,7-Dichloro-9-[(4-chlorophenyl)methylene]-alpha-[(dibutylamino)methyl]-9H-fluorene-4-methanol
- 2-(dibutylamino)-1-{(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl}ethanol
- 2-Dibutylamino-1-[2,7-dichloro-9-[1-(4-chlorophenyl)meth-(Z)-ylidene]-9H-fluoren-4-yl]ethanol
- 9H-Fluorene-4-methanol, 2,7-dichloro-9-[(4-chlorophenyl)methylene]-α-[(dibutylamino)methyl]-, (9Z)-
- 9H-Fluorene-4-methanol, 2,7-dichloro-9-[(4-chlorophenyl)methylene]-α-[(dibutylamino)methyl]-, (Z)-
- Benflumelol
- dl-Benflumelol
Lumefantrine is a drug that belongs to the class of antimalarial drugs. It is used for the treatment of malaria caused by Plasmodium falciparum, and has been shown to be effective against chloroquine-resistant strains. Lumefantrine inhibits polymerase chain reaction by binding to the β subunit of DNA polymerase, thereby preventing mRNA transcription. The rate constant for lumefantrine was calculated using data from environmental stressors such as heat and cold, and from long-term toxicity studies in rats. Lumefantrine has also been shown to have cardiac effects through its ability to inhibit the activity of α1-acid glycoprotein. This drug inhibits p-glycoprotein (Pgp), which is an ATP-dependent efflux pump located on the cell membrane that pumps out drugs from cells. Pgp inhibitors are useful in combination with other chemotherapeutic agents, such as doxorubicin or vincristine
Chemical properties
Technical inquiry about: 3D-FL24956 Lumefantrine
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.